Lee Jennifer Kayden bought RYTM
August 13, 2026 · Form 4 insider transaction
Lee Jennifer Kayden bought 21,601 shares of Rhythm Pharmaceuticals, Inc. at $6.80 per share, a transaction worth $146.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
21,601
Price
$6.80
Total value
$146.9K
InsiderLee Jennifer Kayden
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 13, 2026
Filing dateAugust 14, 2026
Shares owned after75,834
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercises and sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2026.